Robotic-Assisted Bronchoscopy-Guided Synchronous Biopsy and Radiofrequency Ablation for Pulmonary Nodules
Starting soon · Not applicable
Conditions studied: Pulmonary Nodules
In brief
This is a prospective, single-arm, open-label clinical study. The primary study objective is to evaluate the feasibility of synchronous biopsy and radiofrequency ablation for pulmonary nodules under robotic-assisted bronchoscopy.
Key facts
- Study ID
- NCT07545057
- Run by
- Shanghai Chest Hospital
- People needed
- 76
- Starts
- 2026-05-01
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-04-28
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 18 years old;
- Chest CT indicates pulmonary nodules, highly suspected of being malignant;
- Size of pulmonary nodules: 8 mm < maximum diameter ≤ 30 mm, and the number of pulmonary nodules requiring intervention ≤ 3;
- Preoperative imaging evaluation indicates no clear lymph node metastasis or distant metastasis (cT1N0M0);
- Multidisciplinary evaluation shows that the patient cannot tolerate surgery and radiotherapy, or the patient refuses surgery and radiotherapy after full informed consent;
- The patient understands and agrees to receive synchronous biopsy and ablation treatment under robotic-assisted bronchoscopy and signs a written informed consent form.
You may not qualify if…
- Patients who cannot tolerate general anesthesia due to advanced age or severe cardiopulmonary diseases, or other reasons;
- The target nodule has been diagnosed as a malignant tumor or metastasis;
- Patients with severe bleeding tendency or uncorrectable coagulation disorder (platelet count < 50×10\^9 /L, prothrombin time > 18s, prothrombin activity < 40%);
- Severe pulmonary fibrosis and pulmonary hypertension;
- Anticoagulant or anti-platelet drugs have not been discontinued for the required time before surgery;
- Implanted cardiac pacemaker, defibrillator, or other electronic implants;
- Presence of important blood vessels that cannot be avoided along the biopsy path;
- Other conditions that the investigators consider not suitable for the patient to participate in this study.
Where it is running
- Shanghai Chest Hospital — Shanghai, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.